Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Huimou Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-7914-0918; OpenAlex author ID A5006195312. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 4 papers · 2026: 3 papers

Papers 12

  1. Cancer-associated fibroblasts drive gemcitabine resistance in pancreatic cancer by promoting ferroptosis resistance via the PAX6/PAK3/SLC3A2 axis. Co-author DOI 10.1016/j.canlet.2026.218381↗
  2. circMTHFD1L-driven lipid metabolism in Cancer-associated fibroblasts confers oxaliplatin resistance in pancreatic cancer through O-GlcNAcylation-dependent chro… Co-author DOI 10.1016/j.canlet.2026.218863↗
  3. Lactylation-driven NSUN2-mediated RNA m5C modification promotes perineural invasion in pancreatic cancer. Co-author DOI 10.7150/thno.122294↗
  4. Liver diseases, transaminases, and hepatobiliary-pancreatic cancer risk: a cohort and Mendelian randomisation study using data from UK Biobank. Co-author DOI 10.1136/bmjgast-2025-001870↗
  5. Cancer-Associated Fibroblasts Foster a High-Lactate Microenvironment to Drive Perineural Invasion in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-24-3173↗
  6. Cancer-associated fibroblast-derived circKLHL24 drives perineural invasion in pancreatic cancer via dual regulation of the sec31a-CXCL12 axis. Co-author DOI 10.1186/s13046-025-03489-2↗
  7. Unexpected complete remission after recurrence in pancreatic cancer: a case report on comprehensive multimodal therapy. First author DOI 10.3389/fonc.2025.1582673↗
  8. Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in … First author DOI 10.1016/j.canlet.2022.215859↗
  9. HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1. Co-author DOI 10.1016/j.ebiom.2019.05.013↗
  10. The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1. Co-author DOI 10.1007/s13277-015-4234-0↗
  11. Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-rela… First author DOI 10.1016/j.canlet.2015.12.010↗
  12. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. Co-author DOI 10.1186/s12967-015-0442-z↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shangyou Zheng · 11 shared papers, 2015–2026 · strength 1.98
  2. Rihua He · 6 shared papers, 2025–2026 · strength 1.42
  3. Chengyuan Hu · 4 shared papers, 2025 · strength 0.92
  4. Tianhao Huang · 3 shared papers, 2025–2026 · strength 0.72
  5. Chonghui Hu · 3 shared papers, 2025–2026 · strength 0.71
  6. Rufu Chen · 3 shared papers, 2025–2026 · strength 0.69
  7. Zhihua Li · 2 shared papers, 2026 · strength 0.55
  8. Rufu Chen · 2 shared papers, 2025 · strength 0.48
  9. Yong Jiang · 2 shared papers, 2025–2026 · strength 0.46
  10. Yuan Yuan · 2 shared papers, 2025 · strength 0.43
  11. Zhiqiang Fu · 3 shared papers, 2015–2026 · strength 0.39
  12. Guolin Li · 2 shared papers, 2016–2025 · strength 0.27
  13. Xiaohui Zhao · 4 shared papers, 2015–2022 · strength 0.26
  14. Wenchao Gao · 4 shared papers, 2015–2022 · strength 0.26
  15. Wenzhu Li · 4 shared papers, 2015–2022 · strength 0.26
  16. Yimin Liu · 4 shared papers, 2015–2022 · strength 0.26
  17. Zhihua Li · 4 shared papers, 2015–2022 · strength 0.26
  18. Tian Qing · 1 shared paper, 2026 · strength 0.25
  19. Rufu Chen · 1 shared paper, 2026 · strength 0.25
  20. Yu Zhou · 1 shared paper, 2026 · strength 0.24
  21. Shizong Li · 1 shared paper, 2025 · strength 0.22
  22. Tingting Li · 1 shared paper, 2025 · strength 0.22
  23. Yingxue Wang · 3 shared papers, 2016–2022 · strength 0.22
  24. Yu Zhou · 1 shared paper, 2025 · strength 0.22
  25. Quanbo Zhou · 3 shared papers, 2015–2022 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.